BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33029928)

  • 1. Sequential intermittent therapeutic plasma exchange: A possible induction and maintenance therapy in the management of adult patients with neuromyelitis optica spectrum disorder.
    Viswanathan S; Schee JP; Omar MA; Hiew FL
    Ther Apher Dial; 2021 Aug; 25(4):513-532. PubMed ID: 33029928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders and Related Disorders in Resource-Limited Settings: Outcomes in a Multiethnic Single-Center Population.
    Ong ZM; Schee JP; Viswanathan S
    Ther Apher Dial; 2020 Jun; 24(3):312-323. PubMed ID: 31654607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
    Aungsumart S; Apiwattanakul M
    Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
    Siritho S; Nopsopon T; Pongpirul K
    J Neurol; 2021 Dec; 268(12):4549-4562. PubMed ID: 33037886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy of plasma exchange versus intravenous immunoglobulin as an add-on therapy in acute attacks of neuromyelitis optica spectrum disorder.
    Siwach G; Hans R; Takkar A; Ahuja CK; Lamba DS; Lal V; Sharma RR
    J Clin Apher; 2024 Jun; 39(3):e22129. PubMed ID: 38850074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of therapeutic apheresis in patients with refractory neuromyelitis optica spectrum disorders: a single-center retrospective study.
    Zhang L; Zhuang Y; Liu X; Xu Q; Zhou L; Zou L; Jiang Y; Tian J; Yao H; Chi H; Qiu X; Yang T; Wang D; Yu Y
    Ann Palliat Med; 2021 Mar; 10(3):3105-3114. PubMed ID: 33752428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee.
    Ipe TS; Raval JS; Fernando LP; Gokhale A; Jacquot C; Johnson AD; Kim HC; Monis GF; Mo YD; Morgan SM; Pagano MB; Pham HP; Sanford K; Schmidt AE; Schwartz J; Waldman A; Webb J; Winters JL; Wu Y; Yamada C; Wong ECC
    J Clin Apher; 2020 Jan; 35(1):25-32. PubMed ID: 31705563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of plasma exchange in neuromyelitis optica spectrum disorder: A systematic review and meta-analysis.
    Kosiyakul P; Songwisit S; Ungprasert P; Siritho S; Prayoonwiwat N; Jitprapaikulsan J
    Ann Clin Transl Neurol; 2020 Nov; 7(11):2094-2102. PubMed ID: 32956562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders-Experience from Tertiary Care Center in North India.
    Hans R; Prakash S; Sharma RR; Sankhyan N; Takkar A; Goyal M; Saikia B; Lal V; Marwaha N
    Neurol India; 2022; 70(2):710-713. PubMed ID: 35532644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Li Z; Wan L; Liu X; Wang J; Shi X; Zhou H; Xu Q; Wei S; Yang G
    Front Immunol; 2022; 13():1113406. PubMed ID: 36685590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease course, progression and activity of neuromyelitis optica (NMOSD) in patients who were treated with Rituximab, 6 and 12 months after receiving the first dose of drug, in Isfahan city.
    Ashtari F; Mehdipour R; Shaygannejad V; Mansourian M
    Mult Scler Relat Disord; 2019 Sep; 34():77-82. PubMed ID: 31233958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Exchange for Neuromyelitis Optica Spectrum Disorders in Chinese Patients and Factors Predictive of Short-term Outcome.
    Jiao Y; Cui L; Zhang W; Zhang Y; Wang W; Zhang L; Tang W; Jiao J
    Clin Ther; 2018 Apr; 40(4):603-612. PubMed ID: 29606515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders.
    Gonzalez C; Vargas D; Contreras K; Garcia P; Rodriguez P; Zarco L; Navas C
    Ther Apher Dial; 2022 Dec; 26(6):1274-1280. PubMed ID: 35353437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Rituximab on relapse rate and disability in an Ecuadorian cohort of patients with neuromyelitis optica spectrum disorders.
    Correa-Díaz EP; Torres-Herrán GE; Miño Zambrano JE; Paredes-Gonzalez V; Caiza-Zambrano FJ
    Mult Scler Relat Disord; 2021 Feb; 48():102683. PubMed ID: 33338945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder.
    Zhou Y; Zhong X; Shu Y; Cui C; Wang J; Wang Y; Li X; Chen Z; Peng L; Kermode A; Qiu W
    Mult Scler Relat Disord; 2019 Feb; 28():213-220. PubMed ID: 30623860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
    Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
    Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.
    Khatri BO; Kramer J; Dukic M; Palencia M; Verre W
    J Clin Apher; 2012; 27(4):183-92. PubMed ID: 22488449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of plasma exchange for neuromyelitis optica spectrum disorders: A meta-analysis.
    Huang X; Wu J; Xiao Y; Zhang Y
    Mult Scler Relat Disord; 2021 Feb; 48():102709. PubMed ID: 33385827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX.
    Songthammawat T; Srisupa-Olan T; Siritho S; Kittisares K; Jitprapaikulsan J; Sathukitchai C; Prayoonwiwat N
    Mult Scler Relat Disord; 2020 Feb; 38():101506. PubMed ID: 31731214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders.
    Song W; Qu Y; Huang X
    Int Ophthalmol; 2019 Nov; 39(11):2477-2483. PubMed ID: 30825049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.